LENZ Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| LENZ | SRZN | YDES | LONA | KLRS | ZNTL | |
|---|---|---|---|---|---|---|
| Market cap | 113.43M | 291.02M | 448.36M | 58.08M | 53.80M | 247.27M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -1.2 | -5.9 | — | — | -1.4 | -1.4 |
| Price/book | 0.5 | -1.3 | 1.4 | 1.7 | 0.9 | 1.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −90.65% | +114.83% | −63.54% | +53.74% | −50.42% | +62.96% |
| Today | −0.96% | −16.60% | −5.94% | +7.22% | −4.24% | −4.55% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All LENZ news ›LENZ Therapeutics, Inc. Stock 12‑Month Price Target Cut to $22, Implies 504% Upside
TradingView LENZ Therapeutics, Inc. Stock 12‑Month Price Target Cut to $22, Implies 504% Upside - According to estimates from 6 analysts, LENZ Therapeutics, Inc. stock's average price target has fallen from $25 to $22, with forecasts…
Analyzing Eloxx Pharmaceuticals (NASDAQ:ELOX) & LENZ Therapeutics (NASDAQ:LENZ)
Posted by Mitch Edgeman on Sep 29th, 2026 LENZ Therapeutics (NASDAQ:LENZ – Get Free Report) and Eloxx Pharmaceuticals (NASDAQ:ELOX – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
themarketsdaily.com1
-
tradingview.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 2 articles, not a forecast.